title: Comment on Hong et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes care 2013;36:1304-1311.
authors.affiliation: Corresponding author: Søren Søgaard Lund, soeren.lund@boehringer-ingelheim.com.
authors.forename: Søren Søgaard
authors.initials: SS
authors.lastname: Lund
authors.forename: Yan
authors.initials: Y
authors.lastname: Gong
mesh_terms: D003324:Coronary Artery Disease / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005913:Glipizide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008687:Metformin / Q000627:therapeutic use*
chemical_list: D008687:Metformin; D005913:Glipizide